Skip to main content
Log in

Dengvaxia could be cost effective in dengue-endemic countries

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2014 US dollars

Reference

  • Lee JS, et al. A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia. Vaccine : 12 Mar 2018. Available from: URL: http://doi.org/10.1016/j.vaccine.2018.03.002

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dengvaxia could be cost effective in dengue-endemic countries. PharmacoEcon Outcomes News 801, 13 (2018). https://doi.org/10.1007/s40274-018-4868-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4868-4

Navigation